Sugi Predict

Sugi Predict / Targets / TNPO3

TNPO3

Transportin-3 · Q9Y5L0 · TNPO3 on Sugi Atlas →

0 patent compounds predicted against TNPO3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TNPO3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
Effect of, OAT3, on the Renal Secretion of Cefotaxime PHASE1COMPLETED
Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain nanCOMPLETED
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders nanRECRUITING
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
Pulmonary Hypertension--Mechanisms and Family Registry nanCOMPLETED
18F-FDG PET/TC in TIR3A e TIR3B nanENROLLING_BY_INVITATION
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) nanWITHDRAWN
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study nanACTIVE_NOT_RECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Brain P-gp and Inflammation in People With Epilepsy nanCOMPLETED
Investigation of Copy Number Variations and Genetic Variants in POI nanRECRUITING
Precision Medicine for Nociception, Sngception and Proprioception. nanRECRUITING
Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH) nanRECRUITING
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Biopsies of Cancer Patients for Tumor Molecular Characterization nanCOMPLETED
Genetic Analysis of Parkinson's Disease nanCOMPLETED
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods nanUNKNOWN
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Iron Overload in African Americans nanCOMPLETED
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Monogenic Diabetes Misdiagnosed as Type 1 nanRECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TNPO3 binder may also engage these)

ProteinNameSimilarity
Q6P2B1 — 1.000 Q6P2B1 →
O94829 — 0.985 O94829 →
Q8K0C1 — 0.984 Q8K0C1 →
A7YWD2 — 0.984 A7YWD2 →
Q5R974 — 0.983 Q5R974 →
Q9JM04 — 0.981 Q9JM04 →
XPO6 Exportin-6 0.981 landscape →
Q924Z6 — 0.981 Q924Z6 →
Q5ZIC8 — 0.980 Q5ZIC8 →
Q96JC1 — 0.967 Q96JC1 →
XPOT Exportin-T 0.966 landscape →
Q5RA02 — 0.966 Q5RA02 →
Q96JJ3 — 0.964 Q96JJ3 →
Q5E964 — 0.963 Q5E964 →
PSMD13 26S proteasome non-ATPase regulatory subunit 13 0.962 landscape →
Q9CRT8 — 0.962 Q9CRT8 →
Q6NTZ5 — 0.962 Q6NTZ5 →
Q5RCC1 — 0.961 Q5RCC1 →
Q9WVJ2 — 0.961 Q9WVJ2 →
Q8R5L3 — 0.961 Q8R5L3 →
Q8BHL5 — 0.959 Q8BHL5 →
P84169 — 0.959 P84169 →
B0BN93 — 0.959 B0BN93 →
A9UHW6 — 0.959 A9UHW6 →
Q5R644 — 0.958 Q5R644 →
Q8QHJ8 — 0.958 Q8QHJ8 →
Q53I77 — 0.957 Q53I77 →
Q3ZC21 — 0.957 Q3ZC21 →
A4FUD6 — 0.956 A4FUD6 →
USP9X Ubiquitin carboxyl-terminal hydrolase 9X 0.955 landscape →